Keywords: protherics, angiotensin, vaccine, promising, uk, reported, encouraging

Protherics' angiotensin vaccine promising

Article | 01 April 2002

Print This

Protherics of the UK has reported encouraging data from its early PhaseII trials program for its angiotensin vaccine which indicate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in